Guiding Business Development for Franchise Development
Coactuate collaborated with a top 5 global pharma to prototype a new approach to medium-to-long-term R&D pipeline strategy, molecule selection and portfolio management. Combining evidence-based research with a comprehensive patient journey, Coactuate along with a broad cross-functional client team developed a new framework for molecule sourcing and prioritization. The framework was pressure tested and iterated with a wide range of disease area leaders to ensure its relevance and applicability across the Business Development function.
The new business development framework is being implemented within a disease area to inform new molecule sourcing and long-term franchise lifecycle strategy. An internal team is replicating the process for other disease areas.